FDA Warning Letter — Colgate Oral Pharmaceuticals, Inc.

Case 436771 — FEI 1000117969

The FDA took a Warning Letter action against Colgate Oral Pharmaceuticals, Inc. on Aug 7, 2014 (Dallas, TX). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Colgate Oral Pharmaceuticals, Inc.
Date
Aug 7, 2014
Fiscal Year
2014
Product Type
Drugs
Center
CDER
Location
Dallas, TX (United States)